In this study, we demonstrated that dopamine transporter (DAT) levels are significantly reduced in FTD compared to controls, with a symmetrical loss observed in both the putamen and the caudate, particularly in patients with genetically confirmed disease. Here, SLC6A3 is linked to frontotemporal dementia.